A detailed history of Trustcore Financial Services, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 208,806 shares of CORT stock, worth $10.9 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
208,806
Previous 208,806 -0.0%
Holding current value
$10.9 Million
Previous $5.35 Million 20.81%
% of portfolio
0.38%
Previous 0.51%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

BUY
$16.53 - $25.21 $9,422 - $14,369
570 Added 0.27%
208,806 $4.7 Million
Q4 2021

Feb 09, 2022

SELL
$17.1 - $23.34 $144,648 - $197,433
-8,459 Reduced 3.9%
208,236 $4.12 Million
Q3 2021

Nov 08, 2021

BUY
$19.68 - $22.53 $2.56 Million - $2.93 Million
130,000 Added 149.95%
216,695 $4.27 Million
Q1 2021

Apr 30, 2021

SELL
$23.49 - $30.56 $469,799 - $611,200
-20,000 Reduced 18.75%
86,695 $2.06 Million
Q4 2020

Feb 04, 2021

BUY
$16.78 - $27.3 $767,936 - $1.25 Million
45,765 Added 75.11%
106,695 $2.79 Million
Q3 2020

Nov 02, 2020

BUY
$12.46 - $19.98 $500,393 - $802,396
40,160 Added 193.36%
60,930 $1.06 Million
Q2 2020

Jul 29, 2020

SELL
$11.0 - $18.26 $695,178 - $1.15 Million
-63,198 Reduced 75.26%
20,770 $349,000
Q4 2019

Jan 30, 2020

BUY
$12.06 - $16.96 $770,634 - $1.08 Million
63,900 Added 318.42%
83,968 $1.02 Million
Q3 2019

Oct 30, 2019

SELL
$10.41 - $14.66 $307,095 - $432,470
-29,500 Reduced 59.51%
20,068 $284,000
Q1 2019

May 07, 2019

BUY
$10.03 - $15.71 $497,167 - $778,713
49,568 New
49,568 $582,000
Q4 2018

Feb 05, 2019

SELL
$11.29 - $17.19 $559,622 - $852,073
-49,568 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$12.27 - $15.65 $602,272 - $768,180
49,085 Added 10162.53%
49,568 $695,000
Q1 2018

May 04, 2018

BUY
$14.59 - $25.5 $7,046 - $12,316
483 New
483 $8,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.59B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.